Physician profile
Evetta Lavern Borden
NPI 1215946702
$385.39
in general payments reported to CMS, 2019-2025
10 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2023: $57.86 · 2024: $41.07 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $106.17 | 2025 | Restrata Wound Matrix |
| Wright Medical Technology, INC. | $92.23 | 2019 | |
| Advanced Oxygen Therapy INC. | $46.71 | 2023-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Organogenesis INC. | $34.73 | 2019-2024 | Apligraf |
| Axogen | $28.08 | 2023 | Avance Nerve Graft |
| Convatec INC. | $20.63 | 2023 | |
| Paratek Pharmaceuticals, INC. | $18.08 | 2025 | Nuzyra |
| Bioventus LLC | $16.59 | 2024 | Exogen Ultrasound Bone Healing System |
| Electronic Waveform Lab, INC. | $11.58 | 2025 | |
| Orpyx Medical Technologies US INC. | $10.59 | 2025 | Orpyx Custom Sensory Insole System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evetta Borden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.